News | September 18, 2012

Supplies and devices, such as stents, accounted for the largest proportion of hospital inpatient cost increases between 2001 and 2006.

MRI Systems Clinical Trial/Study Stents Cath Lab Health Service Research

September 18, 2012 — Inpatient hospital treatment accounts for the largest proportion of healthcare spending in the United States, with the use of diagnostic imaging services such as magnetic resonance images (MRIs) frequently implicated as the probable cause. A new analysis finds that the biggest expense may not be from imaging technology, but from supplies including medical devices, such as stents and artificial joints.

“One of the takeaway messages for hospitals is that they should examine their own data in closer detail to explore the costs that are rapidly rising and have a better understanding for the underlying reasons,” said lead author Jared Lane Maeda, Ph.D., of Truven Health Analytics in Washington, D.C.

The study — released in Health Services Research — used the 2001 and 2006 Healthcare Cost and Utilization Project State Inpatient Databases and Medicare Cost Reports for community, non-rehabilitation hospitals in nine states. The researchers conducted a cost analysis on more than 10.2 million patient discharges for various conditions.

At 24.2 percent of costs, “supplies and devices,” (defined as the “supply items required for patient care”) were the leading contributors to the increase in average cost per discharge. Intensive care unit charges contributed 17.6 percent, and room and board for a semi-private room was 11.3 percent. Imaging, such as computed tomography (CT) scans, and other advanced technological services contributed just 4.9 percent. The significant growth in the mean cost per discharge of supplies and devices suggests they should be examined more closely.

Caroline Steinberg, vice president of Trends Analysis for the American Hospital Association, said the group supports comparative effectiveness research to determine whether new drugs and devices are both clinically and cost effective. “This is an area where more research is needed,” she added. “And as for increased use of the intensive care unit, that is consistent with the trend towards older and sicker patients.”

Maeda added that payers might consider negotiating discounts in areas of care and cost that are growing quickly.

For more information: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1475-6773/


Related Content

News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
News | Contrast Media

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...

Time September 21, 2023
arrow
News | Artificial Intelligence

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
Sponsored Content | Case Study | Radiology Imaging | By Tim Hodson

In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...

Time September 19, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Christine Book

The world of medical imaging is marking a significant milestone in 2023: the 50th anniversary of magnetic resonance ...

Time September 19, 2023
arrow
News | Artificial Intelligence

September 11, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is ...

Time September 11, 2023
arrow
News | Lung Imaging

September 11, 2023 — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced magnetic ...

Time September 11, 2023
arrow
News | PET-CT

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

Time September 08, 2023
arrow
Subscribe Now